Barentz Elevates Matt Mitchell to Global Vice President of Pharmaceuticals

HOOFDDORP, Netherlands — Barentz, a leading global distributor and provider of specialty ingredient solutions, has officially announced the permanent appointment of Matt Mitchell as its Global Vice President, Pharmaceuticals.

Mitchell, who had been serving as the Interim Head of the Pharmaceuticals Division since March 2026, has been confirmed for the role following a rigorous selection process. During his tenure as interim leader, Mitchell was instrumental in navigating the business through a phase of robust growth and operational excellence, earning him a continued seat on the Barentz Executive Leadership Team.

A Wealth of Industry Expertise

With a distinguished career spanning over 25 years, Mitchell possesses deep-rooted experience in the specialty ingredients sector. Before joining Barentz, he held various high-level leadership positions at industry powerhouses including IFF Pharma Solutions, DuPont, and FMC. This extensive background has allowed him to develop a nuanced understanding of the complex global pharmaceutical landscape.

In his permanent role, Mitchell will be tasked with overseeing the company’s strategic direction, focusing on expanding the specialty ingredients portfolio and strengthening Barentz’s competitive position in the life sciences market.

Strategic Continuity and Growth

Christian Barker, Chief Commercial Officer at Barentz, lauded Mitchell’s performance during the transition period. “Matt has demonstrated exceptional leadership, strategic insight, and a strong commitment to our customers, principals, and teams around the world,” Barker stated. “His appointment ensures continuity while positioning our Pharmaceuticals division for continued success and growth.”

For his part, Mitchell expressed enthusiasm about the future of the division, emphasizing the strength of the firm’s existing partnerships and its potential for further expansion.

“I am honored to take on this role permanently and continue working alongside our talented global team,” Mitchell said. “We have a strong business, exceptional partnerships, and significant opportunities ahead. I look forward to building on our momentum and delivering continued value for our customers, principals, and colleagues.”

As the pharmaceutical industry continues to evolve, Barentz aims to leverage Mitchell’s expertise to drive innovation and provide sophisticated, tailor-made solutions to its global client base.